<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04709016</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A02182-37</org_study_id>
    <nct_id>NCT04709016</nct_id>
  </id_info>
  <brief_title>Drug Use During Sex and Its Impact on Taking PrEP (Pre-Exposure Prophylaxis) : CONSUME</brief_title>
  <acronym>CONSUME</acronym>
  <official_title>The Use of Chemsex (Drug Use in a Sexual Context) Among MSM (Men Who Have Sex With Men) and Transgender People in France, Whether or Not Taking PrEP, and Its Impact on PrEP Adherence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a cross-sectional, single-center observational study conducted from October 2020 to&#xD;
      March 2021 in Ile de France at the infectious disease of CHU Bichat (PrEP and CeGIDD(Free&#xD;
      Center for Information, Screening and Diagnosis of Infections by Human Immunodeficiency&#xD;
      Viruses, Viral Hepatitis and Sexually Transmitted Infections) consultation). It concerns&#xD;
      adult subjects of male or transgender sex, of MSM (men having sex with men) or bi-sexual&#xD;
      orientation. The data are collected by self-questionnaire evaluating the consumption of&#xD;
      Chemsex (drug use in a sexual context) over the last 12 months, the existence or not of&#xD;
      addiction treatment, the history of STIs (sexually transmitted infections) and adherence to&#xD;
      PrEP (for subjects taking PrEP) during the last sexual intercourse (ANRS questionnaire, used&#xD;
      in the PREVENIR study).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 18, 2021</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>compare in an MSM and transgender population, the use of Chemsex depending on whether or not PrEP is taken</measure>
    <time_frame>inclusion</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reported adherence to PrEP</measure>
    <time_frame>inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The existence or not of psychological comorbidity and the existence of addictological care</measure>
    <time_frame>inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The number of sexually transmitted infections at inclusion</measure>
    <time_frame>inclusion</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">250</enrollment>
  <condition>Drug Dependence</condition>
  <arm_group>
    <arm_group_label>male or transgender patients</arm_group_label>
    <description>of sexual orientation MSM (men having sex with men) or bi-sexual, consultant in sexual health centers</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>self-questionnaire</intervention_name>
    <description>self-questionnaire assessing Chemsex's (drug use in a sexual context) consumption over the last 12 months</description>
    <arm_group_label>male or transgender patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study concerns subjects of male or transgender sex, of MSM or bi-sexual sexual&#xD;
        orientation, consulting in sexual health centers.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age&gt; 18&#xD;
&#xD;
          -  male or transgender&#xD;
&#xD;
          -  MSM or bi-sexual orientation&#xD;
&#xD;
          -  adult consultant at Bichat Hospital (CeGIDD or PrEP consultation)&#xD;
&#xD;
          -  adult with a Smartphone (online self-questionnaire)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  For the group &quot;taking PrEP&quot;: adult taking PrEP for less than 3 months&#xD;
&#xD;
          -  Refusal of participation&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>male or transgender MSM or bi-sexual orientation</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>SMIT - Hôpital Bichat</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>January 7, 2021</study_first_submitted>
  <study_first_submitted_qc>January 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 14, 2021</study_first_posted>
  <last_update_submitted>May 10, 2021</last_update_submitted>
  <last_update_submitted_qc>May 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chemsex</keyword>
  <keyword>PrEP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

